- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on May 16, 2022 at 00:00:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| May 16, 2022 | T-895-21 | CMC | 7294140 Canada Inc. Dba Zoomtoner V. Bargain Club Inc. Et Al. (Trade Mark) | Toronto | 30 m |
| May 16, 2022 | T-130-22 | JR | Abbvie Corporation Et Al. V. The Minister Of Health Et Al. (unknown - Adalimumab* - JR) | Toronto | 1.3 d |
| May 16, 2022 | T-10-22 | JR | Abbvie Corporation Et Al. V. Minister Of Health Et Al. (unknown - Adalimumab* - JR) | Toronto | 1.3 d |
| May 17, 2022 | T-415-20 | MED | Frac Shack Inc. Et Al. V. Kva Fuel Services Ltd. (Patent) | Edmonton | 1 d |
| May 17, 2022 | T-1109-21 | M | Liberty Staffing Services Inc. V. Liberty Employment Group Inc. (Trade Mark) | Toronto | 30 m |
| May 18, 2022 | T-1906-17 | CMC | Medisca Pharmaceutique Inc. V. Maxima Pharmaceuticals Inc. (Trade Mark) | Montréal | 15 m |
| May 18, 2022 | T-1338-17 | M | Philip Poyntz Et Al V. Elcargo Fabrication Inc. (Patent) | Ottawa | 2 h |
| May 19, 2022 | T-1441-20 | CMC | Janssen Inc. Et Al V. Pharmascience Inc. (Patent - Paliperidone*) | Toronto | 30 m |
| May 19, 2022 | T-374-21 | CMC | Vidã?otron Ltã?e Et Al C. Technologies Konek Inc. Et Al (Copyright) | Ottawa | 1 h |
| May 19, 2022 | T-1488-20 | CMC | Steelhead Lng (aslng) Ltd Et Al. V. Seven Gens Energy Ltd, Rockies Lng Et Al (Patent) | Ottawa | 1 h |
| May 19, 2022 | T-6-20 | JR | Actial Farmaceutica S.r.l. V. Minister Of Health (unknown - JR) | Toronto | 1 d |
| May 19, 2022 | T-1869-21 | TMC | Bayer Inc. Et Al. V. Sandoz Canada Inc. (Patent - Riociguat*) | Ottawa | 1.5 h |
| May 20, 2022 | T-343-20 | M | The Noco Company, Inc. V. Canadian Tire Corporation, Limited (Patent) | Toronto | 2 h |
| May 20, 2022 | T-1485-20 | CMC | Teva Canada Innovn & Teva Can Ltd V. Mylan Pharma Ulc & Yeda Research & Devt (Patent - Glatiramer*) | Ottawa | 1 h |
| May 20, 2022 | T-952-20 | M | Google Llc V. Sonos, Inc. (Patent) | Ottawa | 1.5 h |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Jun 13, 2022 | T-952-20 | Google Llc V. Sonos, Inc. (Patent) | Toronto | 10 d |
| Jul 4, 2022 | T-1441-20 | Janssen Inc. Et Al V. Pharmascience Inc. (Patent - Paliperidone*) | Toronto | 10 d |
| Jul 4, 2022 | T-558-22 | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Paliperidone*) | Toronto | 10 d |
| Aug 8, 2022 | T-449-17 | Farmobile, Llc. V. Farmers Edge Inc. (Patent) | Vancouver | 20 d |
| Aug 15, 2022 | T-604-19 | Arysta Lifescience North America Et Al V. Agracity Crop Et Al (Patent) | Calgary | 15 d |
| Sep 6, 2022 | T-252-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 12 d |
| Sep 6, 2022 | T-251-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 12 d |
| Sep 12, 2022 | T-202-17 | Travel Leaders Group, Llc V. 204293 Ontario Inc. Dba Travel Leaders (Trade Mark) | Toronto | 10 d |
| Sep 12, 2022 | T-16-21 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Sandoz Canada Inc. (Patent - Linagliptin*) | Toronto | 15 d |
| Sep 21, 2022 | T-1049-18 | Re/max, Llc V. Save Max Real Estate, Inc. Et Al. (Trade Mark) | Vancouver | 13 d |
| Sep 29, 2022 | T-252-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 2 d |
| Sep 29, 2022 | T-251-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 2 d |
| Oct 17, 2022 | T-592-21 | Astrazeneca Canada Inc. Et Al V. Teva Canada Limited (Patent - Dapagliflozin*) | Toronto | 10 d |
| Oct 17, 2022 | T-126-19 | Tekna Plasma Systems Inc. V. Ap&c Advanced Powders & Coatings Inc. (Patent) | Montréal | 15 d |
| Oct 17, 2022 | T-1790-17 | Valley Blades Ltd. V. Usinage Pro-24 Inc. C/o/b As Nordik Blades (Patent) | Ottawa | 7 d |
| Oct 17, 2022 | T-416-19 | Usinage Pro-24 Inc. V. Valley Blades Ltd. (Patent) | Ottawa | 7 d |
| Oct 31, 2022 | T-383-21 | Astrazeneca Canada Inc. Et Al V. Sandoz Canada Inc. (Patent - Dapagliflozin*) | Toronto | 9 d |
| Nov 9, 2022 | T-126-19 | Tekna Plasma Systems Inc. V. Ap&c Advanced Powders & Coatings Inc. (Patent) | Montréal | 2 d |
| Nov 14, 2022 | T-561-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-1686-18 | Wheel Monitor Inc. V. Cleral Inc. Et Al (Patent) | Toronto | 10 d |
| Nov 14, 2022 | T-581-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-577-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-573-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-572-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-560-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-559-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-557-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 20 d |
| Nov 14, 2022 | T-1252-19 | Modpro Containers Ltd Et Al. V. Tangle Pools Et Al. (unknown) | Vancouver | 5 d |
| Nov 14, 2022 | T-1533-20 | Boehringer Ingelheim (canada) Ltd Et Al V. Teva Canada Limited (Patent - Linagliptin*) | Toronto | 15 d |
| Nov 14, 2022 | T-1531-20 | Boehringer Ingelheim (canada) Ltd Et Al V. Teva Canada Limited (Patent - Linagliptin*) | Toronto | 15 d |
| Nov 21, 2022 | T-2060-19 | 9209-6601 Quã?bec Inc. C. Rep Solution Interactive Inc. (Trade Mark) | Montréal | 8 d |
| Dec 5, 2022 | T-1213-21 | Lundbeck Canada Inc. Et Al. V. Apotex Inc. Et Al. (Patent - Vortioxetine*) | Toronto | 10 d |
| Dec 5, 2022 | T-668-21 | Lundbeck Canada Inc. Et Al. V. Apotex Inc. Et Al. (Patent - Vortioxetine*) | Toronto | 10 d |
| Dec 5, 2022 | T-919-21 | Maoz Betser-zilevitch V. Canadian Natural Resources Ltd. (Patent) | Toronto | 7 d |
| Dec 13, 2022 | T-592-21 | Astrazeneca Canada Inc. Et Al V. Teva Canada Limited (Patent - Dapagliflozin*) | Toronto | 1 d |
| Dec 15, 2022 | T-383-21 | Astrazeneca Canada Inc. Et Al V. Sandoz Canada Inc. (Patent - Dapagliflozin*) | Toronto | 1 d |
| Dec 19, 2022 | T-560-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-581-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-577-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-573-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-572-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-561-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-559-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-557-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 3 d |
| Jan 9, 2023 | T-1007-20 | Medexus Pharmaceuticals Inc. Et Al. V. Accord Healthcare Inc. Et Al (Patent) | Ottawa | 14 d |
| Jan 16, 2023 | T-250-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 10 d |
| Jan 16, 2023 | T-249-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 13, 2023 | T-512-20 | 2660722 Ontario Inc. Et Al. V. Vanpak Limited Et Al. (unknown) | To be determined (TrialJA) | 10 d |
| Feb 20, 2023 | T-374-21 | Vidã?otron Ltã?e Et Al C. Technologies Konek Inc. Et Al (Copyright) | Montréal | 8 d |
| Feb 20, 2023 | T-343-20 | The Noco Company, Inc. V. Canadian Tire Corporation, Limited (Patent) | Toronto | 7 d |
| Feb 27, 2023 | T-788-21 | Boehringer Ingelheim (canada) Ltd. Et Al V. Jamp Pharma Corporation (Patent - Linagliptin*) | Toronto | 15 d |
| Mar 3, 2023 | T-343-20 | The Noco Company, Inc. V. Canadian Tire Corporation, Limited (Patent) | Toronto | 1 d |
| Mar 20, 2023 | T-703-20 | Kaira District Coop Milk Producers Union Ltd Et Al V Amul Canada Ltd Et Al (Trade Mark) | Toronto | 5 d |
| Apr 11, 2023 | T-711-20 | Bell Canada V. Skychoice Communications Inc. (Trade Mark) | Toronto | 8 d |
| Jun 5, 2023 | T-379-21 | Molo Design, Ltd. V. Chanel Canada Ulc Et Al. (Patent) | Montréal | 10 d |
| Jun 5, 2023 | T-1966-21 | Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*) | To be determined (TrialJA) | 8 d |
| Jun 5, 2023 | T-1168-21 | Dr. Reddy's Laboratories Ltd. Et Al V. Janssen Inc, Et Al (Patent) | Toronto | 10 d |
| Jun 19, 2023 | T-1966-21 | Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*) | To be determined (TrialJA) | 2 d |
| Jun 19, 2023 | T-607-21 | Apotex Inc. V. Janssen Inc. Et Al. (Patent - Abiraterone*) | Toronto | 10 d |
| Jul 10, 2023 | T-1475-21 | Pharmacyclics Llc Et Al. V. Natco Pharma (canada) Inc. (Patent - Ibrutinib*) | Toronto | 15 d |
| Jul 10, 2023 | T-1472-21 | Pharmacyclics Llc Et Al. V. Natco Pharma (canada) Inc. (Patent - Ibrutinib*) | Toronto | 15 d |
| Sep 11, 2023 | T-1994-21 | Allergan, Inc. Et Al. V. Juno Pharmaceuticals Corp. (Patent - Bimatoprost*) | Toronto | 10 d |
| Sep 11, 2023 | T-1962-21 | Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*) | To be determined (TrialJA) | 5 d |
| Sep 21, 2023 | T-1962-21 | Bausch Health Ireland Ltd Et Al V. Apotex Inc. (Patent - Efinaconazole*) | To be determined (TrialJA) | 2 d |
| Sep 25, 2023 | T-1869-21 | Bayer Inc. Et Al. V. Sandoz Canada Inc. (Patent - Riociguat*) | Toronto | 2 d |
| Oct 3, 2023 | T-15-22 | Boehringer Ingleheim (canada) Ltd. Et Al V. Pharmascience Inc. (Patent - Linagliptin*) | Toronto | 16 d |
| Oct 3, 2023 | T-1869-21 | Bayer Inc. Et Al. V. Sandoz Canada Inc. (Patent - Riociguat*) | Toronto | 4 d |
| Oct 10, 2023 | T-1869-21 | Bayer Inc. Et Al. V. Sandoz Canada Inc. (Patent - Riociguat*) | Toronto | 4 d |
| Oct 16, 2023 | T-214-22 | Bristol-myers Squibb Canada Co. Et Al. V. Jamp Pharma Corporation (Patent - Apixaban*) | Toronto | 10 d |
| Oct 16, 2023 | T-653-21 | Apotex Inc. V. Servier Canada Inc. (Patent - Perindopril*) | Toronto | 10 d |
| Oct 16, 2023 | T-151-22 | Takeda Canada V. Apotex, Takeda Pharmaceutical Co & Takeda Pharma Usa (Patent - Dexlansoprazole*) | To be determined (TrialJA) | 10 d |
| Oct 30, 2023 | T-962-21 | Sandoz Canada Inc. V. Hoffmann-la Roche Limited Et Al (Patent - Pirfenidone*) | Toronto | 9 d |
| Oct 30, 2023 | T-192-22 | Novartis Pharmaceuticals Canada Inc. Et Al. V. Teva Canada Limited (Patent - Sacubitril*) | Ottawa | 10 d |
| Nov 9, 2023 | T-151-22 | Takeda Canada V. Apotex, Takeda Pharmaceutical Co & Takeda Pharma Usa (Patent - Dexlansoprazole*) | To be determined (TrialJA) | 2 d |
| Nov 17, 2023 | T-962-21 | Sandoz Canada Inc. V. Hoffmann-la Roche Limited Et Al (Patent - Pirfenidone*) | Toronto | 1 d |
| Nov 20, 2023 | T-1386-21 | Jcai Inc. V. Wiseleap Solutions Inc. Et Al (Patent) | To be determined (TrialJA) | 12 d |
| Nov 27, 2023 | T-409-22 | Celgene Inc. Et Al. V. Jamp Pharma Corporation (Patent - Pomalidomide*) | Toronto | 10 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| May 16, 2022 | T-130-22 | Abbvie Corporation Et Al. V. The Minister Of Health Et Al. - Adalimumab* | S. 18.1 Application for Judicial Review | Toronto | 1.3 d |
| May 16, 2022 | T-10-22 | Abbvie Corporation Et Al. V. Minister Of Health Et Al. - Adalimumab* | S. 18.1 Application for Judicial Review | Toronto | 1.3 d |
| May 19, 2022 | T-6-20 | Actial Farmaceutica S.r.l. V. Minister Of Health | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| May 25, 2022 | T-1581-21 | Anheuser-busch, Llc V. H.o.w. Medical Solultions Ltd. | Trade Mark - Appeal of a decision of the Registrar | Montréal | 2 h |
| Jun 1, 2022 | T-1172-21 | Standard International Management Llc V. Asia Standard Management Services L | Trade Mark - Appeal of a decision of the Registrar | Toronto | 1 d |
| Jun 2, 2022 | T-1749-21 | Divert Inc. V. Resource Recovery Fund Board Inc. | Trade Mark - Appeal of a decision of the Registrar | Ottawa | 1 d |
| Jun 16, 2022 | T-1488-21 | 101217990 Saskatchewan Ltd Dba District Brewing Company V. Lost Craft Inc. | Others - not provided for anywhere else [Actions] | Vancouver | 1 d |
| Aug 8, 2022 | T-349-21 | Cheung's Bakery Products Ltd. V. Easywin Ltd. | Trade Mark Opposition | Vancouver | 1 d |
| Sep 20, 2022 | T-1561-20 | G N R Travel Centre Ltd. V. Cwi, Inc. Et Al. | Trade Mark - Appeal of a decision of the Registrar | Winnipeg | 1 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location | Length |
| Jun 1, 2022 | A-149-21 | Hoffman-laroche Limited Et Al V. Sandoz Canada Inc - Pirfenidone* | Appeal (S.27 - Final) - Others | Toronto | 1 d |
| Jun 16, 2022 | A-23-22 | Farmers Edge Inc. V. Farmobile, Llc | Appeal (S.27 - Interloc.) - Patent Act | Vancouver | 3 h |
| Jun 22, 2022 | A-32-21 | Pharmascience Inc. V. Bristol Myers Squibb Et Al - Apixaban* | Appeal (S.27 - Final) - Patent Act | Toronto | 1.3 d |
| Jun 22, 2022 | A-33-21 | Sandoz Canada Inc. V. Bristol-myers Squibb Canada Co. Et Al - Apixaban* | Appeal (S.27 - Final) - Patent Act [from T-503-19 - Patented Medicines (NOC) Regulations [Actions]] | Toronto | 1.3 d |
| Jun 22, 2022 | A-34-21 | Sandoz Canada Inc. V. Bristol-myers Squibb Canada Co. Et Al - Apixaban* | Appeal (S.27 - Final) - Patent Act [from T-504-19 - Patented Medicines (NOC) Regulations [Actions]] | Toronto | 1.3 d |
| Jun 22, 2022 | A-31-21 | Pharmascience Inc. V. Bristol-myers Squibb Canada Co. Et Al - Apixaban* | Appeal (S.27 - Final) - Patent Act | Toronto | 1.3 d |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.